ABSTRACT
In Kenya, HIV diagnosis is not routinely carried out in infants, and yet rapid diagnosis could improve access to lifesaving interventions. A cheap and readily accessible service can resolve this problem, if feasible. In this pilot study the feasibility and costs of provision of an infant HIV diagnosis service in Kenya are evaluated. Dried blood spots (DBS) were collected from infants exposed to HIV, sent to a central testing laboratory and tested using the Roche Amplicor v. 1.5 DNA PCR kit. The results were then dispatched to health facilities within a week. A total of 15.4% of the samples tested HIV+ despite the widespread access to prevention of mother to child transmission (PMTCT) programs in Kenya. The cost per test at 21.50 USD is prohibitive and will limit access to diagnosis. It remains to be seen whether the increase in testing will immediately lead to an increase in access to antiretroviral therapy (ART) services for infants.
Subject(s)
Blood/virology , HIV Infections/diagnosis , HIV-1/isolation & purification , Mass Screening/economics , Specimen Handling/methods , Anti-Retroviral Agents/therapeutic use , DNA, Viral/genetics , DNA, Viral/isolation & purification , Enzyme-Linked Immunosorbent Assay , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , HIV-1/genetics , Humans , Infant , Kenya/epidemiology , Male , Mass Screening/methods , Mothers , Pilot Projects , Polymerase Chain Reaction/economics , Polymerase Chain Reaction/methods , Poverty , Prevalence , Sensitivity and Specificity , Specimen Handling/economicsABSTRACT
Eight genotypes of hepatitis B virus (A-H) and subgenotypes have been recognized worldwide. However, there is limited information on prevalent genotypes in many countries in Africa. This study was undertaken to determine the hepatitis B virus (HBV) genotypes in Kenya. Seropositive HBV blood samples from a blood donor setting were used in the study. HBV genotypes were determined in 52 nucleic acid-positive samples using specific primer in a nested PCR and sequencing employed in the HBV genotyping. This study shows presence of HBV variants with genotypes A (88%), E (8%) and D (4%). In conclusion, we found that HBV genotype A is the most predominant genotype in Kenya with both subgenotype A1 and A2 present. Genotype D and E are also present in our population. This demonstrates that there could be a high genetic diversity of HBV in Kenya.
Subject(s)
DNA, Viral/genetics , Genetic Variation , Hepatitis B virus/genetics , Hepatitis B/virology , Genotype , Hepatitis B Surface Antigens/genetics , Hepatitis B virus/classification , Hepatitis B virus/isolation & purification , Humans , Kenya , Molecular Sequence Data , PhylogenyABSTRACT
To identify tickborne viruses circulating in Kenya and the surrounding region, we conducted surveillance at abattoirs in Nairobi, Kenya. Species of ticks collected included Rhipicephalus pulchellus (56%), Amblyomma gemma (14%), R. appendiculatus (8%), A. variegatum (6%), and others. A total of 56 virus isolates were obtained, 26 from A. gemma, 17 from R. pulchellus, 6 from A. variegatum, and 7 from other species. Virus isolates included Dugbe virus (DUGV), an unknown virus related to DUGV, Thogoto, Bhanja, Kadam, Dhori, Barur, and foot-and-mouth disease (FMDV) viruses. This is the first report of Dhori virus isolation in East Africa and the first known isolation of FMDV associated with tick collection. Our results demonstrate the potential for tickborne dissemination of endemic and emergent viruses and the relevance of A. gemma in the maintenance of tickborne viruses in this region.
